Clinical trial NCT05613712: Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine
Official title: Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Chronic Inflammatory Disease
Keywords: rheumatoid arthritis
spondyloarthropathy
spondylarthritis
ankylosing spondylitis
psoriatic arthritis
chronic inflammatory rheumatic diseases
comorbidities
continuity of patient care
patient compliance
adherence
non-adherence
Lead sponsor: University Hospital, Grenoble
Sponsor class: OTHER
First posted: 2022-11-14
Enrollment: 400
Sex: ALL
Minimum age (years): 18
Maximum age (years): 90
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: The SCORIC population targeted by the patient questionnaire represents all patients followed by the rheumatology department of the CHU Grenoble Alpes, having benefited from a holistic analysis of their disease and their comorbidities.

The referring physician population will be generated from the medical records of the patients of the SCORIC cohort.

Brief summary: Identification of factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes

Detailed description: In the rheumatology department of the CHU Grenoble Alpes, Professor Baillet and other rheumatologists have set up a holistic assessment of inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) and associated co-morbidities in a day hospital. Based on this assessment, a hospital report is drawn up summarising the patient's treatment options, which is then sent to the patient's referring physician. They analysed the first 100 patients in the cohort and showed that 98% of patients were not up to date with their care. Their longitudinal analysis shows that patients update two thirds of the recommendations made within 12 to 18 months. Therefore, the investigators would like to assess the applicability of this screening in these patients, through a questionnaire sent to the 400 patients of the cohort and to their treating physicians.

Eligibility criteria: Inclusion Criteria:

* Patient cohort :
* men and women over 18 years of age
* Informed volunteers who have consented to participate in the study
* have rheumatoid arthritis, spondyloarthritis or psoriatic arthritis
* have been hospitalised in a day hospital in the rheumatology department of the Grenoble-Alpes University = SCORIC cohort of the department
* Cohort of referring physicians :
* volunteers who received informed information and consented to participate in the study
* be the referring physician of a patient of the SCORIC cohort of the rheumatology department of the South Hospital of the CHU Grenoble-Alpes

Exclusion Criteria:

* Patient cohort :
* psychiatric pathologies or history of behavioural disorders
* persons referred to in articles L1121-5 to L1121-8 of the Public Health Code
* persons under guardianship or curatorship
* not affiliated to the social security system
* minors
* Refusal to participate by the patient and/or unreturned questionnaire
* Cohort of referring physicians:
* the physician is no longer the patient's referring physician
* refusal of the doctor to participate and/or questionnaire not returned

Primary outcomes:
measure: Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes, through questionnaires
timeFrame: 1 day
Secondary outcomes:
measure: Elements limiting the good ambulatory follow-up, according to the patients
timeFrame: 1 day
measure: Elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes, according to the patients
timeFrame: 1 day
Other outcomes:
Locations:
city: Grenoble
country: France
facility: CHU Grenoble Alpes
Study officials:
affiliation: CHU Grenoble Alpes
name: Xavier ROMAND, PHD
role: PRINCIPAL_INVESTIGATOR
References: